An Open-label, Randomized, Single Centre, 4-way Crossover Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ezogabine/Retigabine in Healthy Adult Taiwanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2017
At a glance
- Drugs Retigabine (Primary)
- Indications Epilepsy; Postherpetic neuralgia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
- 30 Jun 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 30 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History